The New York Center for Nanomedicine Research in Buffalo has signed a strategic development agreement with a Canadian research center.
The 12-month agreement with the International Centre for Advancement of Health Regional Innovation and Science (ICAHRIS) in Ottawa is intended to advance non-invasive nanotechnologies for the early detection and treatment of a variety of diseases, including cancer and diabetes.
ICAHRIS focuses on regional innovation strategies, infrastructure and competitiveness…
The New York Center for Nanomedicine Research in Buffalo has signed a strategic development agreement with a Canadian research center.
The 12-month agreement with the International Centre for Advancement of Health Regional Innovation and Science (ICAHRIS) in Ottawa is intended to advance non-invasive nanotechnologies for the early detection and treatment of a variety of diseases, including cancer and diabetes.
ICAHRIS focuses on regional innovation strategies, infrastructure and competitiveness…